Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Friday, down -10.52% from the previous trading day, before settling in for the closing price of $5.18. Over the past 52 weeks, ORGO has traded in a range of $2.61-$7.08.
While this was happening, its average annual earnings per share was recorded 1617.00%. With a float of $59.06 million, this company’s outstanding shares have now reached $126.91 million.
Organogenesis Holdings Inc (ORGO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 53.46%, while institutional ownership is 54.10%. The most recent insider transaction that took place on Dec 16 ’25, was worth 1,027,060. In this transaction Director of this company sold 200,000 shares at a rate of $5.14, taking the stock ownership to the 2,565,591 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director proposed sale 200,000 for $5.11, making the entire transaction worth $1,021,241.
Organogenesis Holdings Inc (ORGO) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.07 earnings per share (EPS), higher than consensus estimate (set at 0.02) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1617.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 2.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 0.18 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
As of the previous 9 days, the stock’s Stochastic %D was 11.43%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 24.56%, which indicates a significant increase from 1.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.06, while its 200-day Moving Average is $4.43. However, in the short run, Organogenesis Holdings Inc’s stock first resistance to watch stands at $5.02. Second resistance stands at $5.40. The third major resistance level sits at $5.61. If the price goes on to break the first support level at $4.43, it is likely to go to the next support level at $4.23. Should the price break the second support level, the third support level stands at $3.84.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
The company with the Market Capitalisation of 588.24 million has total of 126,912K Shares Outstanding. Its annual sales at the moment are 482,040 K in contrast with the sum of 860 K annual income. Company’s last quarter sales were recorded 150,860 K and last quarter income was 21,570 K.
